Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Evolent Health Inc

Healthcare US EVH

3.07USD
0.03(0.99%)

Last update at 2026-03-10T20:00:00Z

Day Range

2.943.10
LowHigh

52 Week Range

23.3336.70
LowHigh

Fundamentals

  • Previous Close 3.04
  • Market Cap3556.86M
  • Volume2800625
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA107.89M
  • Revenue TTM1790.27M
  • Revenue Per Share TTM16.61
  • Gross Profit TTM 316.58M
  • Diluted EPS TTM-1.03

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -62.07700M -29.80100M -337.79900M -327.11600M -54.15100M
Minority interest - 0.00000M 0.00000M -3.60900M -1.53300M
Net income -18.70100M -30.28400M -334.24600M -305.58000M -52.65800M
Selling general administrative 245.75M 219.50M 310.55M 392.82M 306.31M
Selling and marketing expenses - - - - -
Gross profit 316.58M 250.41M 321.06M 333.32M 299.24M
Reconciled depreciation 67.19M 60.04M 61.48M 60.91M 44.52M
Ebit -59.83500M 30.25M -37.88200M -120.40900M -52.77100M
Ebitda 7.36M 90.28M 23.59M -65.46600M -8.25600M
Depreciation and amortization 67.19M 60.04M 61.48M 54.94M 44.52M
Non operating income net other 6.00M 13.59M -38.71900M -5.47800M -1.29600M
Operating income -59.83500M 30.25M -37.88200M -120.40900M -47.48000M
Other operating expenses 1371.89M 937.09M 1073.40M 966.79M 678.65M
Interest expense 15.57M 25.43M 28.34M 14.53M 5.48M
Tax provision -43.37600M 0.48M -3.55300M -21.53600M 0.04M
Interest income 9.63M 0.41M 3.16M 3.99M 3.44M
Net interest income -14.20300M -25.01800M -25.17300M -10.54700M -2.04400M
Extraordinary items -0.46300M -7.31700M 3.60M 1.61M 0.30M
Non recurring - - 215.10M 199.80M -
Other items - - - - -
Income tax expense -43.37600M 0.48M -3.55300M -21.53600M 0.04M
Total revenue 1352.01M 907.96M 1022.43M 846.38M 627.06M
Total operating expenses 336.46M 279.54M 372.03M 453.73M 350.82M
Cost of revenue 1035.43M 657.55M 701.37M 513.06M 327.82M
Total other income expense net -2.24200M -60.04900M -299.91700M -206.70700M -0.52300M
Discontinued operations -0.46300M -7.31700M -6.07400M 1.61M 1.61M
Net income from continuing ops -18.70100M -30.28400M -334.24600M -301.97100M -52.65800M
Net income applicable to common shares -19.16400M -37.60100M -334.24600M -301.97100M -52.65800M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 1817.29M 1419.46M 1370.18M 1498.02M 1722.28M
Intangible assets 442.78M 279.78M 268.07M 308.46M 335.04M
Earning assets - - - - -
Other current assets 451.10M 435.30M 524.43M 200.46M 98.82M
Total liab 957.88M 725.83M 750.59M 568.97M 532.92M
Total stockholder equity 859.42M 693.63M 619.60M 922.36M 1143.82M
Deferred long term liab 4.74M 1.40M 0.73M 1.94M 25.44M
Other current liab 363.39M 330.40M 321.47M 129.18M 102.01M
Common stock 1.01M 0.91M 0.86M 0.85M 0.82M
Capital stock 1.01M 0.91M 0.86M 0.85M 0.82M
Retained earnings -606.15400M -626.77900M -589.17800M -251.96200M 50.01M
Other liab 55.44M 6.93M 455.17M 13.67M 42.53M
Good will 722.77M 426.30M 354.73M 572.06M 768.12M
Other assets 32.30M 52.39M 186.47M 91.99M 121.14M
Cash 188.20M 266.28M 340.49M 101.01M 228.32M
Cash and equivalents 188.20M 266.28M 319.00M 101.01M 228.32M
Total current liabilities 433.44M 445.49M 401.78M 192.77M 146.76M
Current deferred revenue 5.76M 11.94M 14.33M 19.83M 20.58M
Net debt 287.92M 14.19M 19.29M 267.79M -7.27900M
Short term debt 7.12M 7.07M 33.91M 6.27M -122.59600M
Short long term debt - - 26.56M - -
Short long term debt total 476.12M 280.47M 359.78M 368.79M 221.04M
Other stockholder equity 1465.73M 1319.87M 1208.20M 1173.71M 1093.17M
Property plant equipment 87.87M 81.36M 86.24M 85.16M 73.63M
Total current assets 478.05M 523.96M 546.13M 228.80M 487.97M
Long term investments 4.47M 5.46M 17.42M 139.37M 16.29M
Net tangible assets -306.14100M -12.44800M -3.20600M 41.84M 40.66M
Short term investments 14.49M 75.69M 3.86M 1.81M 0.82M
Net receivables 254.68M 130.60M 126.31M 77.42M 82.31M
Long term debt 412.99M 215.68M 263.34M 293.67M 221.04M
Inventory -415.92600M -308.22200M -445.09800M -150.08600M 78.51M
Accounts payable 57.17M 96.08M 32.07M 37.49M 146.76M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - 6.69M 45.53M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -1.17800M -0.36200M -0.27800M -0.23400M -0.18200M
Additional paid in capital - - - - -
Common stock total equity 1.01M 0.91M 0.86M 0.85M 0.82M
Preferred stock total equity - - - - -
Retained earnings total equity -606.15400M -626.77900M -589.17800M -251.96200M 50.01M
Treasury stock - -21.12300M -21.12300M - -
Accumulated amortization - - - - -
Non currrent assets other 32.30M 12.98M 7.27M 8.26M 6.11M
Deferred long term asset charges - - - - -
Non current assets total 1339.24M 895.50M 824.05M 1269.21M 1113.17M
Capital lease obligations 63.13M 64.79M 69.88M 75.13M -
Long term debt total 412.99M 215.68M 263.34M 293.67M 221.04M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 36.52M 54.22M -10.06400M -93.70000M 8.92M
Change to liabilities -16.88600M 7.73M 31.66M -23.44100M 17.38M
Total cashflows from investing activities -259.11500M -15.78600M 261.07M -181.63400M -160.37500M
Net borrowings 219.74M -98.84900M 13.46M -41.62000M 263.33M
Total cash from financing activities 131.54M -29.54800M -11.86200M -35.54500M 274.02M
Change to operating activities -8.11800M -14.37700M -2.90600M 0.24M -16.14200M
Net income -19.16400M -37.60100M -334.24600M -305.58000M -54.19100M
Change in cash -139.78400M -6.63900M 233.05M -259.79400M 92.96M
Begin period cash flow 354.94M 361.58M 128.53M 388.32M 295.36M
End period cash flow 215.16M 354.94M 361.58M 128.53M 388.32M
Total cash from operating activities -11.55300M 38.75M -16.22500M -42.64500M -20.65100M
Issuance of capital stock - - - 0.00000M 0.00000M
Depreciation 67.19M 60.04M 61.48M 60.91M 44.52M
Other cashflows from investing activities -295.63600M -70.00500M 271.14M -52.40000M -129.74100M
Dividends paid -14.88400M -1.30000M -20.00000M - -
Change to inventory - -14.11600M 47.02M -19.50300M 0.64M
Change to account receivables -102.98000M -5.77900M -47.01700M 6.33M -24.50300M
Sale purchase of stock -10.43200M 11.99M -17.42300M 8.18M 11.93M
Other cashflows from financing activities 146.43M 70.60M 24.74M -35.54500M 274.02M
Change to netincome -26.91400M 17.00M 277.76M 187.90M 18.73M
Capital expenditures 38.36M 24.98M 29.47M 35.53M 39.55M
Change receivables - - - - -
Cash flows other operating -18.08600M -26.46600M -67.65000M 28.20M -49.54400M
Exchange rate changes - - - - -
Cash and cash equivalents changes -139.12700M -6.58700M 232.99M -259.82400M 93.00M
Change in working capital -104.44100M -13.64500M -55.31900M 0.33M -34.86600M
Stock based compensation 33.98M 16.71M 14.61M 15.62M 17.61M
Other non cash items 10.53M 13.77M 298.39M 209.20M 6.24M
Free cash flow -49.91400M 13.76M -45.69800M -78.17900M -60.20100M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EVH
Evolent Health Inc		 0.03 0.99% 3.07 - 27.32 1.98 3.18 2.21 -1536.6582
GEHC
GE HealthCare Technologies Inc.		 -2.9 3.83% 72.73 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A		 -5.88 3.01% 189.69 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 11.42 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 -0.07 1.34% 5.17 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

View All

Profile

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

Evolent Health Inc

800 North Glebe Road, Arlington, VA, United States, 22203

Key Executives

Name Title Year Born
Mr. Frank John Williams Co-Founder & Chairman 1966
Mr. Seth Barrie Blackley Co-Founder, CEO & Director 1979
Mr. John Paul Johnson Chief Financial Officer 1984
Mr. Steve Tutewohl FSA, MAAA Chief Operating Officer 1973
Mr. Aammaad Shams Chief Accounting Officer & Controller 1984
Mr. Jonathan David Weinberg J.D. Chief Legal Officer, Gen. Counsel & Sec. 1968
Mr. Dan McCarthy CEO of New Century Health & Pres NA
Mr. Seth R. Frank VP of Investor Relations NA
Ms. Jessica Somers Sr. VP of Corp. Devel. NA
Ms. Kali Beyah Chief People & Brand Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.